Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCobham Share News (COB)

  • There is currently no data for COB

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

IN THE KNOW: UBS Stays Neutral On Cobham Despite Skipped Dividend

Wed, 11th Jan 2017 10:17

LONDON (Alliance News) - UBS kept a Neutral stance on Cobham, despite the FTSE 250 electronics firm scrapping its final payment after saying 2016 profit will miss its thrice-downgraded guidance.

The Swiss bank noted the defence and aerospace technology group's "long track record of dividend growth".

Shares in Cobham dropped on Wednesday following its announcement, down 15% at 140.03 pence, the worst performer in the mid-cap index.

The stock touched a low of 130.30p earlier on Wednesday, its lowest level since October, when it fell to 129.80p. This was just above a 52-week low of 124.32p touched in May last year, the lowest in 11 years.

Cobham said trading profit for the year to December will be GBP245.0 million, below the guidance range of GBP255.0 million to GBP275.0 million that it provided in October.

The new guidance also is below UBS's profit estimate of GBP263 million.

Cobham said its management team is starting a balance-sheet review, including looking at major contracts and carrying values. The profit guidance it provided on Wednesday is before any adjustments this review may require.

"We believe the main headwinds are still very much related to the short-cycle businesses in Communications & Connectivity and Advanced Electronics Solutions," said UBS analyst Cristian Nedelcu.

In light of the challenges it faces and the "disappointing" 2016 performance, Cobham said it will scrap its final dividend payment for 2016. It paid a 2.030 pence dividend at the interim stage of 2016, down from 2.585p a year before. In 2015, it paid a total dividend of 11.180p.

Despite this decision, UBS noted the company's remarkable record of dividend growth in the past.

"We note Cobham has a long track record of dividend growth ? with 45 consecutive years of increasing dividends as of 2015," Nedelcu said.

Accendo Markets analyst Michael van Dulken, said the latest guidance cut has been "the nail in the coffin" for the final dividend, "perhaps the one thing that had kept the loyal from jumping ship".

Cobham issued a series of profit warnings over the course of 2016, kicking off with a warning in April accompanied by a rights issue to shore up its balance sheet and culminating in another warning in October.

Alongside its neutral stance, UBS retained a price target of 160p on Cobham shares.

By Daniel Ruiz; danielruiz@alliancenews.com

Copyright 2017 Alliance News Limited. All Rights Reserved.

More News
19 Aug 2021 13:18

CMA confirms it will investigate Cobham takeover of Ultra Electronics

(Sharecast News) - The Competition and Markets Authority confirmed on Thursday that it will investigate the proposed takeover of defence company Ultra Electronics by Cobham.

Read more
28 Jun 2021 07:58

Ultra Electronics terminates talks with Cobham

(Sharecast News) - Aerospace and defence group Ultra Electronics was under the cosh on Monday after saying at the end of the last week that it had terminated "very early stages" of exploratory talks with Cobham about a possible combination of some of their units.

Read more
11 Mar 2021 20:35

Babcock sells Oil and Gas aviation unit to CHC Group

(Sharecast News) - Babcock has clinched a deal to hive off its Oil and Gas aviation unit to CHC Group.

Read more
4 Oct 2020 18:03

Sunday newspaper round-up: Trump, Cineworld, Cobham

(Sharecast News) - President Donald Trump's team of doctors says he is doing well after his Covid-19 diagnosis and could be discharged as early as Monday. Dr. Brian Garibaldi, a specialist in pulmonary critical care, said Trump received a second dose of the experimental drug remdesivir along with a first dose of dexamethasone yesterday and isn't showing any side effects "that we can tell." He said Sunday that Trump is "up and well" and the plan was to have him "out of bed" Sunday as much as possible, and could potentially return to the White House to continue his five-day course of remdesivir. - Sunday Telegraph

Read more
15 Jan 2020 12:00

Cobham Days From Exiting Trading As US Private Equity Tie-Up Nears

Cobham Days From Exiting Trading As US Private Equity Tie-Up Nears

Read more
23 Dec 2019 17:02

LIVE MARKETS-Closing snapshot: STOXX anchored at record

* European shares hit fresh lifetime peak* STOXX ends little changed in thin trade* Optimism over trade deal lifts spirits* U.S. stocks also hit fresh record highs Welcome to the home for real-time coverage of European equity markets brought to you ...

Read more
23 Dec 2019 12:50

LIVE MARKETS-New records

* European shares hit new lifetime peak* Optimism over trade deal lifts spirits* U.S. futures hit fresh record highs Welcome to the home for real-time coverage of European equity markets brought to you by Reuters stocks reporters and anchored today...

Read more
23 Dec 2019 09:45

UPDATE: Advent Pledges To Be Good Custodian Of Cobham As Purchase OKed

UPDATE: Advent Pledges To Be Good Custodian Of Cobham As Purchase OKed

Read more
23 Dec 2019 08:45

LIVE MARKETS-Opening snapshot: Atlantia and NMC Health

* European shares seen opening lower* Asian shares idle near 18-month high Welcome to the home for real-time coverage of European equity markets brought to you by Reuters stocks reporters and anchored today by Joice Alves. Reach her on Messenger to...

Read more
23 Dec 2019 07:53

LIVE MARKETS-On our radar: Holidays and M&A

* European shares seen opening lower* Asian shares idle near 18-month high Welcome to the home for real-time coverage of European equity markets brought to you by Reuters stocks reporters and anchored today by Joice Alves. Reach her on Messenger to...

Read more
21 Dec 2019 10:40

Cobham Family Condemns "Cynical" UK Approval Of Defence Firm Takeover

Cobham Family Condemns "Cynical" UK Approval Of Defence Firm Takeover

Read more
21 Dec 2019 08:25

UPDATE 2-Britain gives U.S. investor go-ahead to buy Cobham for $5 bln

(Adds comment by PM Johnson, member of Cobham family)LONDON, Dec 21 (Reuters) - Britain has approved the purchase of British defence company Cobham by U.S. investor Advent International for $5 billion after the private equity group made commitment...

Read more
21 Dec 2019 08:25

UPDATE 1-Britain gives Advent's $5 bln Cobham takeover the green light

(Edits, adds background)LONDON, Dec 21 (Reuters) - Britain has approved Advent International's $5 billion purchase of defence company Cobham after the U.S. private equity group made commitments to address national security concerns.Business minist...

Read more
21 Dec 2019 07:09

Britain approves Advent's $5 billion Cobham purchase

Dec 21 (Reuters) - The British government has approved Advent International's $5 billion purchase of defence company Cobham Plc after the U.S. private equity group offered a number of commitments to address national security concerns."Having consi...

Read more
2 Dec 2019 12:49

Hill & Smith Hires Former Laird Boss Tony Quinlan As Non-Executive

Hill & Smith Hires Former Laird Boss Tony Quinlan As Non-Executive

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.